voacamine has been researched along with Ovarian Neoplasms in 2 studies
*Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kingston, DG; Prakash Chaturvedula, VS; Schilling, JK; Sprague, S | 1 |
| Condello, M; Gallo, FR; Meschini, S; Multari, G; Pellegrini, E; Vecchiotti, D; Zazzeroni, F | 1 |
2 other study(ies) available for voacamine and Ovarian Neoplasms
| Article | Year |
|---|---|
New cytotoxic indole alkaloids from Tabernaemontana calcarea from the Madagascar rainforest.
Topics: Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Female; Humans; Indole Alkaloids; Madagascar; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Ovarian Neoplasms; Plants, Medicinal; Tabernaemontana; Tumor Cells, Cultured | 2003 |
A natural product, voacamine, sensitizes paclitaxel-resistant human ovarian cancer cells.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Ibogaine; Molecular Structure; Ovarian Neoplasms; Paclitaxel | 2022 |